MARKER THERAPEUTICS, INC. Class of Warrant or Right, Outstanding
MARKER THERAPEUTICS, INC. (MRKR) had Class of Warrant or Right, Outstanding of 7.67 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-14
- 2026-06-30: Class of Warrant or Right, Outstanding 7.67M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 7.67M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 7.67M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 7.67M shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2026-06-30 | 7.67M shares 10-Q · filed 2026-08-14 | |
| 2026-03-31 | 7.67M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 7.67M shares 10-Q · filed 2026-08-14 | |
| 2025-09-30 | 7.67M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 7.67M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 7.77M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 8.28M shares 10-K · filed 2026-03-18 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2024-03-26 | |
| 2023-09-30 | 1.85M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 1.85M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 1.85M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 1.85M shares 10-K · filed 2024-03-26 | |
| 2022-09-30 | 18.48M shares 10-Q · filed 2022-11-10 | |
| 2022-06-30 | 18.48M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 19.83M shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 1.98M shares 10-K · filed 2024-03-26 | 19.83M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 19.83M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 20.83M shares 10-Q · filed 2021-08-10 | |
| 2021-03-31 | 20.83M shares 10-Q · filed 2021-05-12 | |
| 2020-12-31 | 2.08M shares 10-K · filed 2023-03-22 | 20.83M shares 10-K · filed 2021-03-09 |
| 2020-09-30 | 20.96M shares 10-Q · filed 2020-11-09 | |
| 2020-06-30 | 21.38M shares 10-Q · filed 2020-08-10 | |
| 2020-03-31 | 21.38M shares 10-Q · filed 2020-05-11 | |
| 2019-12-31 | 22.66M shares 10-K · filed 2022-03-17 | |
| 2019-09-30 | 22.67M shares 10-Q · filed 2019-11-12 | |
| 2019-06-30 | 23.01M shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 23.01M shares 10-Q · filed 2019-05-10 | |
| 2018-12-31 | 23.02M shares 10-K · filed 2021-03-09 | |
| 2018-09-30 | 4.65M shares 10-Q · filed 2018-11-13 | |
| 2018-06-30 | 4.87M shares 10-Q · filed 2018-08-09 | |
| 2017-12-31 | 6.52M shares 10-K · filed 2020-03-12 | |
| 2016-12-31 | 5.06M shares 10-K · filed 2019-03-15 | |
| 2016-09-30 | 5.06M shares 10-Q · filed 2016-11-04 | |
| 2016-08-10 | 3.10M shares 10-K · filed 2018-03-23 | |
| 2015-12-31 | 4.34M shares 10-K · filed 2018-03-23 | 52.11M shares 10-K · filed 2016-04-14 |
| 2014-12-31 | 222.00K shares 10-K · filed 2017-03-14 | 2.66M shares 10-K · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |